A
AltruBio
CA - San Francisco
BiotechnologyFocus: Antibody Therapeutics
AltruBio is a life sciences company focused on Antibody Therapeutics.
Oncology
Funding Stage
SERIES B
Open Jobs
0
Pipeline & Clinical Trials
ALTB-268
Ulcerative Colitis (UC)Clinical Trials (1)
NCT07350577Evaluate the Safety, Tolerability, PK and PD of SAD of Intravenously Adminsterted ALTB-268 in Healthy Participants
Phase 1Phase 1
Clinical Trials (1)
NCT03327857Neihulizumab (ALTB-168) in Patients With Steroid-refractory Acute Graft-versus-host Disease or Treatment-refractory Acute Graft-versus-host Disease
Phase 1ALTB-268
Healthy VolunteersClinical Trials (1)
NCT05723692A First-In-Human SAD and MAD Study to Evaluate the Safety, Tolerability, PK and PD of SC Administered ALTB-268 in Healthy Volunteers
Phase 1ALTB-168
Ulcerative ColitisClinical Trials (1)
NCT03298022Efficacy&Safety of ALTB-168 in Patients With Moderate to Severe Active,Anti-TNF Alpha and/or Anti-integrin Refractory UC
Phase 2ALTB-268
Ulcerative ColitisClinical Trials (1)
NCT06109441Efficacy/Safety of ALTB-268 in Subjects w/Moderately to Severely Active UC Refractory to Biologics
Phase 2Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Portfolio: 5 clinical trials